We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

First-in-Human Trial Evaluating Ebola Treatment Begins

News   May 24, 2018 | Original story from NIH

 
First-in-Human Trial Evaluating Ebola Treatment Begins

A healthy volunteer receives an intravenous infusion of mAb114 -- an experimental treatment for Ebola virus disease -- in a Phase 1 clinical trial held at the NIH Clinical Center in Bethesda, Maryland. Credit: NIAID

 
 
 

RELATED ARTICLES

Fat Fuels Aggressive Brain Cancers

News

Fat is powering tumour growth in brain cancer, finds a new study by Cardiff University and the University of Florida.

READ MORE

Glioblastoma Overcomes Treatment Resistance in Promising Preclinical Study

News

A novel method of overcoming treatment resistance to both PD-1 and adoptive cellular therapy has been identified, by employing a concomitant hematopoietic stem and progenitor cell transfer.

READ MORE

Cryptographic Protocol Enables Greater Collaboration in Drug Discovery

News

MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE